Clinical Trials Browser

Phase 2 × INDUSTRY × peginterferon alfa-2a × Clear all

NCT02576964 2016-11-02

A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular